Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 50 clinical trials
Identification of Predictive Biomarkers for Response to Biologic Therapies in Inflammatory Bowel Disease

ustekinumab will be made at the discretion of the clinician. There will be no random assignment of treatment. The drugs will be used in the approved indications and conditions of use.

inflammatory bowel disease
enteropathy
vedolizumab
infliximab
tumor necrosis factor alpha
  • 32 views
  • 03 Sep, 2021
  • 19 locations
Microbiome Modification to Enhance Stelara Response in Crohn's Disease

-serine diet (vs. a high serine diet) will improve responses in patients initiating therapy with Ustekinumab (Stelara), an FDA-approved biologic therapy for Crohn's disease.

crohn's disease
prednisone
ustekinumab
  • 0 views
  • 04 Jun, 2021
  • 1 location
Assessing Patient Confidence in Biologic Medications

), interleukin 12/23 blockers (ustekinumab) and interleukin 17A blockers (secukinumab, ixekizumab). Due to biologic medication's efficacy and safety profiles, they have revolutionized dermatology and the

infliximab
tumor necrosis factor alpha
ixekizumab
certolizumab pegol
secukinumab
  • 67 views
  • 09 Sep, 2021
  • 1 location
Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children

This is an experimental non-randomized clinical study aimed at expanding the indications for the use of biological drugs with the aim of using them for the pathogenetic therapy of children with congenital ichthyosis.

  • 0 views
  • 17 Aug, 2021
  • 1 location
A Comparative Study of MRI US and CE for Assessing Treatment Response in Known Crohn's Disease

The aim of this study is to evaluate non-invasive imaging techniques for assessing treatment response in known Crohn's disease. Comparing imaging modalities: The applicability of small bowel colon capsule endoscopy (SBCCE), magnetic resonance enterocolonography (MREC) and ultrasound (US) for diagnosing ulcer healing after medical treatment in patients with symptomatic Crohn's …

crohn's disease
endoscopy
ulceration
capsule endoscopy
corticosteroids
  • 5 views
  • 24 Jan, 2021
  • 1 location
The CURE - CD Trial

A prospective randomized three-arms controlled trial of Crohn's Disease (CD) patients in remission of <24 months duration. Patients will undergo screening by Magnetic Resonance Enterography (MRE) and patency capsule, and (if agreeing by separate consent) a baseline colonoscopy. Patients in whom patency of small bowel is proven will undergo video-capsule …

endoscopy
enteropathy
capsule endoscopy
remission
  • 6 views
  • 26 Jan, 2021
  • 1 location
Is the Endoscopic Remission Evaluation Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline Predictive of Sustained Clinical Remission Using a 2-year Follow up

The CREDO 2 study follows CREDO 1 study, which aims to construct an objective evaluation of endoscopic remission in Crohn's Disease (CD). In addition to reproducibility and validation, the predictive value of this remission evaluation needs to be tested in different settings to valorise its usefulness in clinical practice and …

endoscopy
fecal calprotectin
vedolizumab
remission
  • 45 views
  • 08 Jul, 2021
  • 14 locations
A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice

The purpose of this study is to describe the initial response to ustekinumab induction treatment for ulcerative colitis (UC) in Japan.

  • 0 views
  • 08 Sep, 2021
  • 20 locations
Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn s Disease

maintenance therapy of biologics, especially of Ustekinumab, with a special interest on predictors of long-term responses and favorable disease outcome and documentation of severe side effects caused by the

remicade
humira
entyvio
ustekinumab
  • 7 views
  • 22 Jan, 2021
  • 1 location
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease

The purpose of this study is to estimate and compare the incidence of overall malignancy, serious infection, and opportunistic infections between new users of ustekinumab and new users of other

crohn's disease
infliximab
vedolizumab
cancer
adalimumab
  • 0 views
  • 20 Jul, 2021
  • 1 location